Correction To: Resectable Pancreatic Adenocarcinoma Neo-Adjuvant FOLF(IRIN)OX-based Chemotherapy - A Multicenter, Non-Comparative, Randomized, Phase II Trial (PANACHE01-PRODIGE48 Study)
BMC Cancer - United Kingdom
doi 10.1186/s12885-020-6678-x
Full Text
Open PDFAbstract
Available in full text
Date
March 3, 2020
Authors
Publisher
Springer Science and Business Media LLC